Pharmaxi

Executive Summary

Pharmaxi is a mid-sized contract research organization (CRO) based in Kyiv, Ukraine, with operations in Poland and other European countries. Founded in 2014, the company specializes in managing Phase II–IV clinical trials and large-scale non-interventional studies for pharmaceutical and medical device companies. Pharmaxi differentiates itself through a client-oriented, flexible approach and its proprietary electronic data capture (EDC) system, OnlineCRF, which enhances data quality and operational efficiency. Despite the challenging geopolitical environment in Ukraine, Pharmaxi has maintained operations and expanded its footprint across Europe, positioning itself as a reliable partner for sponsors seeking cost-effective clinical trial management. The company's focus on mid-to-late-stage studies and real-world evidence aligns with industry trends toward decentralized and pragmatic trials. While financial details are not publicly available, Pharmaxi's steady growth and client retention suggest a resilient business model. However, dependence on the Ukrainian operational base and regional stability remains a key risk. The company's valuation and total funding are undisclosed, indicating a private, potentially bootstrap-funded entity.

Upcoming Catalysts (preview)

• Q3 2026Expansion of operations into Western Europe or new EU markets65% success
• TBDSecuring strategic partnerships with large pharmaceutical sponsors40% success
• Q1 2027Launch of upgraded proprietary EDC platform with AI-enabled features50% success